« Margin Squeeze: An Overview of EU and National Case Law | Main | Sokol on the Rabbi Cartel »
August 31, 2012
Looking for Sense in the Italian Antitrust Authority Decision in the Pfizer Xalatan Case
Posted by D. Daniel Sokol
Daniela Ampollini (Trevisan & Cuonzo) is Looking for Sense in the Italian Antitrust Authority Decision in the Pfizer Xalatan Case.
ABSTRACT: The January 2012 decision of the Italian Antitrust Authority ("IAA") in the Pfizer case, involving Pfizer's actions to counter the marketing of generic versions of its product Xalatan, has given rise to a debate which has hardly appeased. Many commentators have already provided their impression from a competition law perspective. I, a patent lawyer, will try to provide mine, starting from the meaning and function of the patent law categories involved.
August 31, 2012 | Permalink
TrackBack
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00d8341bfae553ef016768f925bd970b
Listed below are links to weblogs that reference Looking for Sense in the Italian Antitrust Authority Decision in the Pfizer Xalatan Case:
